Investigational Site Number : 0320012

Buenos Aires, Buenos Aires F.D. 1061

0 studies enrolling now · 1 studies all time

What they study most

Celiac Disease, Coeliac Disease

Studies at this site

• A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease — Running, not enrolling